Beyond the "Big Three" (Albumin, IG, and Clotting Factors), the plasma industry produces several high-value, niche proteins that treat rare genetic conditions.
Specific Therapies
Alpha-1 Antitrypsin (AAT): Used to treat Alpha-1 deficiency, a genetic condition that causes severe lung disease (emphysema) and liver damage.
Antithrombin III: A natural anticoagulant. Patients with a deficiency are at extremely high risk for dangerous blood clots (thrombosis), especially during surgery or childbirth.
C1 Esterase Inhibitor: Used to treat Hereditary Angioedema, a condition involving sudden, severe swelling of the face, throat, and abdomen.
3 Views